Stuttgart
05.08.26 | 21:55
0,089 Euro
+4,23 % +0,004
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,089 | 0,094 | 22:37 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.07. | SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion | 381 | Business Wire | Innovation codeveloped in partnership Acceleration of commercial deployment in the United States
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company specializing... ► Artikel lesen | |
| 08.07. | SpineGuard Announces its H1 2026 Revenue | 440 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 26.05. | SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology | 587 | Business Wire | All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills
Regulatory News:
SpineGuard (FR0011464452 ALSGD),... ► Artikel lesen | |
| 28.04. | SpineGuard: Official Launch of Three New PediGuard Models During the Annual Scoliosis Meeting in China | 542 | Business Wire | Presentation of PediGuard in plenary session
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing... ► Artikel lesen | |
| 13.04. | SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard | 406 | Business Wire | Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments Transaction supports SpineGuard's... ► Artikel lesen | |
| 08.04. | SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing | 447 | Business Wire | Operating income improved by 46% Cash runaway extended to 2Q27
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 25.03. | SpineGuard Announces the Full Settlement of the Norgine and Harbert European Growth Bond Issues | 522 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD, PEA-PME eligible), an innovative company deploying its digital surgical guidance (DSG) technology-which measures tissue electrical conductivity... ► Artikel lesen | |
| 19.01. | SpineGuard Reports Its Full-year 2025 Revenue | 471 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology, which measures the electrical conductivity of tissues in real... ► Artikel lesen | |
| 05.01. | SpineGuard Announces its 2026 Financial Calendar | 516 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 17.12.25 | PhD Thesis Presentation of Positive Results Obtained by SpineGuard's New Ultrasound Technology | 491 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 16.12.25 | SpineGuard: Completion of Capital Increase With Priority Period Maintained for a Gross Amount of €1.2 Million | 404 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology based on local measurement of tissue electrical... ► Artikel lesen | |
| 09.12.25 | SpineGuard announces the launch of a capital increase with cancellation of preferential subscription rights and implementation of a priority period for shareholders for an initial gross amount of €1.6 million secured by commitments amounting to... | 633 | Business Wire | Subscription price: €0.1120 per share, representing a discount of 25.93% on the closing price of the share on December 8th, 2025 Priority period open from December 9th, 2025, to December... ► Artikel lesen | |
| 04.12.25 | SpineGuard Obtains the Clearance of Three New PediGuard Models in China | 451 | Business Wire | Extension to add the Curved and XS PediGuard models
Designation change
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 24.11.25 | SpineGuard Obtains a U.S. Patent on Its Universal Adapter for Orthopaedic Power Drills and Robots | 394 | Business Wire | Bone breach detection, automatic stop and additional functionalities
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 09.10.25 | SpineGuard Reports Its Q3 2025 Revenue | 530 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 22.09.25 | SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots | 473 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 10.09.25 | SpineGuard Reports 2025 Half-Year Results and Announces the Implementation of a Bond Financing | 659 | Business Wire | 54% improvement in operating result Implementation of a bond financing for up to €1,000,000
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,650 | +5,16 % | Fresenius hebt nach dem zweiten Quartal den Ergebnisausblick an | ||
| SIEMENS HEALTHINEERS | 39,240 | +0,62 % | Siemens Healthineers Aktie: Diagnostik bremst, Auftragsbestand stützt | Nach den Zahlen zum dritten Geschäftsquartal und der angepassten Jahresprognose bleiben fünf Analystenhäuser bei überwiegend positiven Voten für die Siemens Healthineers Aktie. Die Kursziele bewegen... ► Artikel lesen | |
| THERMO FISHER | 498,90 | +1,90 % | Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings? | ||
| TELADOC HEALTH | 5,958 | +2,48 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 69,34 | +0,41 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| DAVITA | 162,95 | -17,54 % | Aktien New York Ausblick: Dow vor nächstem Rekord - AMD und SpaceX unter Druck | NEW YORK (dpa-AFX) - Die am Vortag begonnene Rekordjagd der US-Leitindizes Dow Jones Industrial und S&P 500 könnte am Mittwoch gleich in die nächste Runde gehen. An der Nasdaq-Börse sieht es aber so... ► Artikel lesen | |
| SPINEWAY | 0,143 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| DENTSPLY SIRONA | 11,900 | -3,95 % | DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? | ||
| SMITH & NEPHEW | 13,000 | -1,52 % | Ihre wichtigsten Termine: Q2-Updates von SpaceX, Bayer, Biontech, Spotify, Pfizer, Continental, Merck & Co | © Foto: Dall-EGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 05:00 Uhr, Großbritannien:... ► Artikel lesen | |
| SONIC HEALTHCARE | 13,560 | -0,48 % | Dividendenbekanntmachungen (04.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPIAL LIFESTYLE LIMITED SG2E90982678 0,008 SGD 0,0053 EUR AUTOLIV INC US0528001094 0,87 USD 0,7491 EUR AVERY DENNISON CORP US0536111091 0... ► Artikel lesen | |
| DIASORIN | 74,82 | +0,08 % | DiaSorin Reports Lower H1 Profit, Confirms FY26 Outlook | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday, reported lower revenue and net profit for the first half of 2026, as higher operating expenses and weaker profitability offset growth recorded... ► Artikel lesen | |
| FULGENT GENETICS | 16,200 | +0,62 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| IMPLANTICA | 5,380 | +1,32 % | Implantica AG: Bulletin from the Annual General Meeting of Implantica AG | Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,554 | -0,93 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results |
Das Unternehmen SPINEGUARD SA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,004 (+4,23 %) liegt der Kurs bei 0,089 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPINEGUARD SA finden Sie auf Wallstreet Online.